| Cardiovascular Risk Management |
1 |
0.9 |
| Type 2 Diabetes Mellitus |
0 |
0.81 |
| Heart |
0 |
0.78 |
| Coronary Artery Disease (CAD) |
0 |
0.73 |
| Heart Failure (HF) |
0 |
0.68 |
| Valvular Heart Disease |
0 |
0.6 |
| Type 1 Diabetes Mellitus |
0 |
0.56 |
| Hypertension |
0 |
0.55 |
| Renal Disease |
0 |
0.51 |
| Cardiometabolic Risk Factors |
0 |
0.9 |
| Cardiomyopathy |
0 |
0.41 |
| Chronic Kidney Disease |
0 |
0.4 |
| Renal Failure |
0 |
0.4 |
| Kidney |
0 |
0.39 |
| Kidney, Ureter, and Bladder |
0 |
0.39 |
| Cerebrovascular Accident |
0 |
0.21 |
| Hospital |
0 |
0.2 |
| Ischemic Stroke |
0 |
0.2 |
| Thromboembolism |
0 |
0.2 |
| Cardiovascular disease |
0 |
0.13 |
| SGLT2 Inhibitor |
0 |
0.11 |
| Artery |
0 |
0.07 |
| Dilated Cardiomyopathy |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.07 |
| Orbit |
0 |
0.07 |
| Retinopathy |
0 |
0.07 |
| Stress |
0 |
0.07 |
| Diabetic Retinopathy |
0 |
0.06 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.04 |
| HIV Infection |
0 |
0.04 |
| Peripheral Artery Disease |
0 |
0.04 |
| Retinal Diseases |
0 |
0.04 |